Changes in the brain serotonin satiety system in transgenic rats lacking brain angiotensinogen

Journal of Neuroendocrinology

Volumn 20, Issue 2, 2008, Pages 182-187

  Voigt, J Peter ^a   Raasch, W ^b   Hortnagl H ^c   Bader, M ^d   Fink, H ^e   Johren O ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

5 HT; 5 HT receptor expression; 5 HTT expression; Fenfluramine; Hypothalamus

Indexed keywords

ANGIOTENSINOGEN; FENFLURAMINE; MESSENGER RNA; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SATIETY; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SPRAGUE DAWLEY RAT; TRANSGENIC RAT; WILD TYPE;

ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BODY WEIGHT; BRAIN; CEREBRAL CORTEX; EATING; FEEDING BEHAVIOR; FENFLURAMINE; HYPOTHALAMUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RNA, MESSENGER; SATIETY RESPONSE; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 38549125576     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01631.x     Document Type: Article

References (24)

1. Voigt JP, Hortnagl H, Rex A, van Hove L, Bader M, Fink H. Brain angiotensin and anxiety-related behavior: The transgenic rat TGR(ASrAOGEN)680. Brain Res 2005; 1046: 145-156.
2. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 1999; 96: 3975-3980.
3. Baltatu O, Afeche SC, Jose dos Santos SH, Campos LA, Barbosa R, Michelini LC, Bader M, Cipolla-Neto J. Locally synthesized angiotensin modulates pineal melatonin generation. J Neurochem 2002; 80: 328-334.
4. Haulica I, Petrescu G, Uluitu M, Rosca V, Slatineanu S. Influence of angiotensin II on dog pineal serotonin content. Neurosci Lett 1980; 18: 329-332.
5. Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ. Angiotensin regulates release and synthesis of serotonin in brain. Science 1978 ; 202: 1091-1093.
6. Mendelsohn FA, Jenkins TA, Berkovic SF. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 1993; 613: 221-229.
7. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. The acute and chronic effects of MDMA ('ecstasy') on cortical 5-HT 2A receptors in rat and human brain. Neuropsychopharmacology 2002 ; 26: 387-396.
8. Voigt J-P, Hoertnagl H, Bader M, Fink H. Effect of brain angiotensin on body weight. Behav Pharmacol 2005; 16: 66.
9. Curzon G, Gibson EL, Oluyomi AO. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 1997; 18: 21-25.
10. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: Effects on appetite expression and use for the treatment of obesity. Drugs 2007; 67: 27-55.
11. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1998.
12. Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001; 142: 3324-3331.
13. Jöhren O, Golsch C, Dendorfer A, Qadri F, Hauser W, Dominiak P. Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 2003; 41: 984-990.
14. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993; 11: 1026-1030.
15. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J Mol Endocrinol 2002; 29: 23-39.
16. Tsujii S, Nakai Y, Fukata J, Nakaishi S, Takahashi H, Usui T, Imura H, Ikeda H, Matsuo T. Monoamine metabolism and its responses to food deprivation in the brain of Zucker rats. Physiol Behav 1988; 44: 495-500.
17. Hall FS, Devries AC, Fong GW, Huang S, Pert A. Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: Relationship to behavior. Synapse 1999; 33: 16-25.
18. Simansky KJ. Serotonergic control of the organization of feeding and satiety. Behav Brain Res 1996; 73: 37-42.
19. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI. Growth, metabolism and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol Genomics 2005; 23: 311-317.
20. Ortlepp JR, Breuer J, Eitner F, Kluge K, Kluge R, Floege J, Hollweg G, Hanrath P, Joost HG. Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia. Eur J Pharmacol 2002; 436: 145-150.
21. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 1998; 274: 867-876.
22. English V, Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 1999; 106: 631-644.
23. Porter JP, Anderson JM, Robison RJ, Phillips AC. Effect of central angiotensin II on body weight gain in young rats. Brain Res 2003; 959: 20-28.
24. Voigt JP, Bramlage P, Fink H. Hypophagic effect of the angiotensin AT(1) receptor antagonist irbesartan in rats. Eur J Pharmacol 2007; 564: 131-137.